Skip to content

Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection

Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02388256
Enrollment
30
Registered
2015-03-13
Start date
2015-03-31
Completion date
2016-04-30
Last updated
2016-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

colon, colorectal, cancer, neoplasm

Brief summary

Background: Patients who undergo laparoscopic surgical resection of colorectal cancer may experience various post-operative symptoms (e.g., pain, nausea and vomiting, and anxiety) and limitation of daily activities (e.g., walking capacity). There is also a risk of post-operative complications and a prolonged hospital stay due to complications. Patients who underwent surgical resection may have experienced chronic pain, anxiety/depression, or diminished quality of life. The physical, psychological, and functional aspects of patients' disorders imply the necessity of multidisciplinary care, including complementary or traditional medicines such as acupuncture. This study aims to assess whether acupuncture treatment, combined with an enhanced recovery program after surgery in an inpatient care setting is effective than only an enhanced recovery program after surgery. Objective: To assess the effectiveness and safety of acupuncture combined with an enhanced recovery program after surgery to reduce postoperative symptoms and improve functional recovery and the patients' quality of life.

Interventions

DEVICEacupuncture

Points of Stomach 36 (ST36), Stomach 37 (ST37), Liver 3 (LR3), Large Intestine 11 (LI11), Large Intestine 4 (LI4), Spleen 6 (SP6), Spleen 4 (SP4) and Pericardium 6 (PC6) will be used. Electrical stimulation with alternating frequency of 2 to 100 Hz will be applied to the selected points (LI4 to LI11, ST36 to ST37, and bilateral SP6). Rationale of acupuncture treatments will include both traditional theory of harmonizing gastrointestinal function and strengthening vital energy as well as modern experimental and clinical evidence of regulating gastrointestinal motility and other symptom managements. Treatments will be provided by qualified hospital staff (Korean medical doctors) with more than 10 years of clinical experience.

OTHERearly recovery program after surgery

An enhanced recovery program after surgery that was designed and is currently implemented by surgeons, anesthetists, dietitians, and nurses will be provided. The program includes preoperative education, early water/food intake, early mobilization, early removal of Foley catheter and drains, structured nursing care, and nutritional support.

Sponsors

Korean Medicine Hospital of Pusan National University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective laparoscopic surgery of colorectal cancer resection (right hemicolectomy, left hemicolectomy, anterior resection with primary anastomosis, and low anterior resection with loop ileostomy for fecal diversion) * Patients aged 18 to 75 * American Society of Anesthesiologists Grade 1 to 2 * Eastern Cooperative Oncology Group Grade 0 to 2 * Written informed consents

Exclusion criteria

* Pregnancy * Inflammatory bowel disease * Comorbidities that may affect outcomes of surgery (e.g., chronic kidney disease, chronic liver disease, cardiopulmonary failure, and diabetes with complications) * Resection of other organs for radical removal of colorectal cancer * Patients requiring enterolysis due to previous history of abdominal surgery * Obstructive colorectal cancer * Metastatic colorectal cancer * Cognitive impairment that may affect the patient's ability to complete the outcome assessments * Previous history of stroke * Previous history of sensitive reaction to acupuncture * Patients unable to cooperate with acupuncture treatments * Pacemaker implantation * Previous history of epilepsy * Patients who have received Korean medicine treatments (acupuncture, moxibustion, cupping, or herbal medicine) within 2 weeks * Patients who have participated in other trials within 3 months

Design outcomes

Primary

MeasureTime frameDescription
Recovery of physical functionat 2 weeks after surgeryRecovery of physical function, as measured by the physical function domain of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) C30 instrument

Secondary

MeasureTime frameDescription
Pain intensityat 4, 12, 24, 48, 72 hours after surgery, at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, and at 4 weeks after surgeryPain scores on a numeric rating scale. Score ranges from 0 (no pain at all) to 10 (the worst pain imaginable)
Time to first flatusup to 1 week after surgery (an expected period of admission)elapsed time after surgery
Time to tolerate soft dietup to 1 week after surgery (an expected period of admission)elapsed time after surgery
Time to first defecationup to 1 week after surgery (an expected period of admission)elapsed time after surgery
Time to independent walkup to 1 week after surgery (an expected period of admission)elapsed time after surgery
Number of insertions of nasogastric tubeup to 1 week after surgery (an expected period of admission)number of insertions of nasogastric tube
Incidence of nausea/vomitingup to 1 week after surgery (an expected period of admission)number of nausea / vomiting reported by the patients
Time to first removal of Foley catheterup to 1 week after surgery (an expected period of admission)elapsed time after surgery
Number of clean intermittent catheterizationsup to 1 week after surgery (an expected period of admission)number of clean intermittent catheterizations
Quality of life measured by EORTC QLQ C30at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgeryQuality of life measured by EORTC QLQ C30
Patient's global assessment after surgeryat 4 weeks after surgery, at 12 weeks after surgeryResponse options include very much improved, somewhat improved, no change, somewhat worsened, and very much worsened.
Use of medicationat 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgeryUse of analgesics, antiemetics and other medications after surgery
Anxiety and depressionat 2 weeks after surgery, at 4 weeks after surgery, at 12 weeks after surgeryPatients' anxiety and depression level measured by the Hospital Anxiety-Depression Scale
Postoperative complicationswithin 12 weeks after surgery* wound infection * urinary tract infection * urinary retention * chest infection * other infection * paralytic ileus
Serious adverse eventswithin 12 weeks after surgery* respiratory failure requiring ventilation * renal failure requiring dialysis * cardiac failure * myocardial infarction * anastomotic leakage requiring surgery * anastomotic leakage requiring drainage * bowel obstruction/stricture requiring surgery * abdominal wall dehiscence requiring surgery * readmission within 30 days after surgery * reoperation within 30 days after surgery * mortality during surgery or within 30 days after surgery
Adverse events related to acupuncturewithin 12 weeks after surgeryExpected or unexpected adverse events that are considered to be associated with acupuncture treatments.
Number of reinsertions of Foley catheterup to 1 week after surgery (an expected period of admission)number of reinsertions of Foley catheter

Other

MeasureTime frameDescription
Adherence to enhanced recovery program after surgeryat 1 week after surgery (an expected day of discharge)Number of patients who discharge the hospital at the expected day as planned

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026